Using a virus to kill a virus
Aug 8
In what represents an important step toward curing HIV, a USC scientist has created a virus that hunts down HIV-infected cells.
Dr. Pin Wang's lentiviral vector latches onto HIV-infected cells, flagging them with what is called "suicide gene therapy" — allowing drugs to later target and destroy them.
"If you deplete all of the HIV-infected cells, you can at least partially solve the problem," said Wang, chemical engineering professor with the USC Viterbi School of Engineering.
The process is analogous to the military practice of "buddy lasing" — that is, having a soldier on the ground illuminate a target with a laser to guide a precision bombing strike from an aircraft.
Like a precision bombing raid, the lentiviral vector approach to targeting HIV has the advantage of avoiding collateral damage, keeping cells that are not infected by HIV out of harm's way. Such accuracy has not been achieved by using drugs alone, Wang said.
So far, the lentiviral vector has only been tested in culture dishes and has resulted in the destruction of about 35 percent of existing HIV cells. While that may not sound like a large percentage, if this treatment were to be used in humans, it would likely be repeated several times to maximize effectiveness.
Among the next steps will be to test the procedure in mice. While this is an important breakthrough, it is not yet a cure, Wang said.
"This is an early stage of research, but certainly it is one of the options in that direction," he said.
###
Wang's research, which was funded by the National Institutes of Health, appears in the July 23 issue of Virus Research.
Contact: Robert Perkinsperkinsr@usc.edu
213-740-9226
University of Southern California
http://www.eurekalert.org/pub_releases/2011-08/uosc-usd080811.php
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Monday, August 8, 2011
USC scientist develops virus that targets HIV
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment